| Group | *P-Value | OR | 95% CI for OR | |||
---|---|---|---|---|---|---|---|
Patient | Control | Lower | Upper | ||||
IKZF1 rs4132601 T > G | |||||||
Genotype | TT | 25 (50%) | 24 (48%) | – | 1.0 | – | – |
TG | 16 (32%) | 20 (40%) | 0.549 | 0.76 | 0.32 | 1.82 | |
GG | 9 (18%) | 6 (12%) | 0.543 | 1.44 | 0.44 | 4.66 | |
Dominant model | TG + GG | 25 (50%) | 26 (52%) | 0.84 | 0.92 | 0.42 | 2.02 |
Recessive model | TT + TG | 41 (82%) | 44 (88%) | 0.4 | 0.62 | 0.20 | 1.90 |
Allele | T | 66 (66%) | 68 (68%) | – | 1.0 | – | – |
G | 34 (34%) | 32 (32%) | 0.764 | 1.09 | 0.60 | 1.97 | |
CDKN2A rs3731217 A > C | |||||||
Genotype | AA | 48 (96%) | 49 (98%) | – | 1.0 | – | – |
AC | 2 (4%) | 1 (2%) | 0.565 | 2.04 | 0.17 | 23.26 | |
CC | 0 (0%) | 0 (0%) | – | – | – | – | |
Allele | A | 98 (98%) | 99 (99%) | – | 1.0 | – | – |
C | 2 (2%) | 1 (1%) | 0.568 | 2.02 | 0.18 | 22.64 | |
CDKN2A rs3731249 C > T | |||||||
Genotype | CC | 41 (82%) | 49 (98%) | – | 1.0 | – | – |
CT | 8 (16%) | 1 (2%) | 0.037 | 9.56 | 1.14 | 79.64 | |
TT | 1 (2%) | 0 (0%) | – | – | – | – | |
Dominant model | CT + TT | 9 (18%) | 1 (2%) | 0.004 | 10.76 | 1.31 | 88.46 |
Recessive model | CC + CT | 49 (98%) | 50 (100%) | 0.24 | 0.00 | 0.00 | NA |
Allele | C | 90 (90%) | 99 (99%) | – | 1.0 | – | – |
T | 10 (10%) | 1 (1%) | 0.024 | 11.00 | 1.38 | 87.64 |